A Study to Evaluate the Persistence of the Antibody Response Elicited by 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Adults who Have Previously Been Vaccinated with With 2 Doses

Grants and Contracts Details

StatusFinished
Effective start/end date1/20/106/30/13

Funding

  • Wyeth Pharmaceuticals Inc: $20,349.00